NCT03463499View on ClinicalTrials.gov

The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

September 30, 2019

Study Completion Date

December 31, 2021

Conditions
Interstitial Cystitis
Interventions
DRUG

Hyaluronic Acid and Chondroitin Sulfate

Intravesical instillation of Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients.

Trial Locations (1)

135-710

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT03463499 - The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients | Biotech Hunter | Biotech Hunter